Clinical trial
Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
NCT01980329 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- March 31, 2014
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cytochrome p450 cyp3a5 enzyme polymorphism, healthy subjects, pharmacokinetics of maraviroc